Regulators pave way for new wave of biosimilar drugs in Europe

Series Title
Series Details 01.07.13
Publication Date 01/07/2013
Content Type

European regulators have cleared the way for the first serious threat to the makers of multibillion-euro biotechnology drugs to treat diseases such as cancer and rheumatoid arthritis.
Source Link http://www.euractiv.com/health/regulators-pave-way-new-wave-bio-news-528990
Related Links
ESO: Background Information: Press Release: Biotech medicines: first biosimilar drug on EU market http://www.europeansources.info/record/press-release-biotech-medicines-first-biosimilar-drug-on-eu-market/
EMA: Press Release: EMA/390722/2013 (28.06.13): European Medicines Agency recommends approval of first two monoclonal antibody biosimilars http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/06/news_detail_001837.jsp&mid=WC0b01ac058004d5c1
Subject Categories ,
Countries / Regions